Central serous chorioretinopathy (CSCR) is a disease which is partly understood. Yet, recent advancements in the imaging techniques have led to further understanding of the disease. Although CSCR is self-limiting, management of recurrent CSCR is necessary. Photodynamic therapy (PDT) is widely used for treating CSCR however , no treatment is considered the standard care for CSCR. This article discusses the current, emerging, and advances in the treatment of CSCR.
Central serous chorioretinopathy (CSCR) is known by many names including capillarospastic central retinitis, central angiospastic retinopathy and central serous retinopathy (CSCR). The hallmark feature of CSCR is the accumulation of subretinal fluid under macula, causing detachment of the retina. However, typical etiology of CSCR remains unknown. Typical symptoms of CSCR include a reduction in the visual acuity, distorted…
